Kindly MD Inc., a Salt Lake City-based non-traditional medical treatment data company, plans to go public, according to a filing with the Securities and Exchange Commission late Wednesday. The company said it plans to offer common stock and tradeable warrants that trade on the Nasdaq under the ticker symbols “KDLY” and “KDLYW,” respectively. WallachBeth Capital LLC was listed as the sole underwriter. The company uses healthcare data focused on better pain management to help reduce the impact of the opioid epidemic. In the filing, Kindly MD said it was “one of the largest providers of medical evaluation and management services related to treatment recommendations within the medical cannabis program in Utah,” serving more than 14,800 active patients, or about 21% of the total Utah medical cannabis patient population. In 2022, the company reported revenue of $3.8 million, and a loss of $2.5 million, or $1.56 a share, versus 2021’s $2.5 million in revenue, and net income of just over $149,000.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Shares of Keurig Dr Pepper Inc. KDP were flat Wednesday after the company named Tim Cofer as chief operating officer and announced he will succeed Chief Executive Bob Gamgort in the second quarter of 2024. Gamgort will serve as executive chairman of KDP after the transition. Cofer, who is CEO of Central Garden & Pet Co. CENT, is scheduled to join Dr Pepper on Nov. 6. Cofer spent more than 25 years with Mondelēz International XE:KTF and its predecessor company, Kraft Foods.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Shares of Enovix Corp. ENVX rose more than 1% in the extended session Wednesday after the battery maker said it has agreed to buy privately held Korean battery maker Routejade in a cash and stock deal. Enovix will pay $16.5 million in cash and about 6.2 million of its shares for the company. “The acquisition provides Enovix with vertical integration of electrode coating and battery-pack manufacturing while adding an established lithium-ion battery business with factories in Korea, along with complementary products, customers, and suppliers,” the Fremont, Calif., company said in a statement. The deal is expected to close in the fourth quarter and it will be “immediately accretive,” Enovix said. Routejade brings more than 20 years of experience as a manufacturer and supplier of lithium-ion batteries in end markets such as wearables, medical, industrial, and the South Korean military, Enovix said. Shares of Enovix ended the regular trading day down 5.4%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

The Biden administration on Wednesday announced that starting Monday U.S. households will again be able to order four free tests for COVID-19 through COVIDTests.gov. The administration also announced an investment of $600 million across 12 domestic manufacturers of COVID tests.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

A trio of Amazon.com Inc. AMZN executives on Wednesday were added to a lawsuit the Federal Trade Commission filed against Amazon in June. Senior Vice Presidents Neil Lindsay and Russell Grandinetti, along with Vice President Jamil Ghani, allegedly participated in a scheme to make it difficult for customers to cancel subscriptions to Amazon’s Prime membership service. The FTC said the three execs helped orchestrate the plan and ignored pleas by employees to stop using techniques “to mislead or trick users” into “signing up for a recurring bill.” An Amazon spokesman said adding the three to the lawsuit was unwarranted. The FTC is expected to file a major antitrust lawsuit against Amazon later this month.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.